Iloperidone
Fanapt (iloperidone) is a small molecule pharmaceutical. Iloperidone was first approved as Fanapt on 2009-05-06. It is used to treat schizophrenia and schizophrenia spectrum and other psychotic disorders in the USA. It is known to target 5-hydroxytryptamine receptor 7, 5-hydroxytryptamine receptor 1A, 5-hydroxytryptamine receptor 6, and D(2) dopamine receptor.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area | MeSH |
---|---|
mental disorders | D001523 |
Trade Name
FDA
EMA
Fanapt (generic drugs available since 2022-05-05)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Iloperidone
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
FANAPT | Vanda Pharmaceuticals | N-022192 RX | 2009-05-06 | 7 products, RLD |
Labels
FDA
EMA
Brand Name | Status | Last Update |
---|---|---|
fanapt | New Drug Application | 2018-09-25 |
iloperidone | ANDA | 2022-12-21 |
Indications
FDA
EMA
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
schizophrenia | EFO_0000692 | D012559 | F20 |
schizophrenia spectrum and other psychotic disorders | — | D019967 | — |
Agency Specific
FDA
EMA
No data
HCPCS
No data
Clinical
Clinical Trials
206 clinical trials
View more details
![](https://www.pharmakb.com/hubfs/raw_assets/public/ccd-theme/images/generated-html-images/trials-plot.png)
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Myeloid leukemia acute | D015470 | C92.0 | 40 | 63 | 18 | 4 | 4 | 104 | |
Myelodysplastic syndromes | D009190 | D46 | 11 | 17 | 6 | 1 | 1 | 29 | |
Precursor cell lymphoblastic leukemia-lymphoma | D054198 | C91.0 | 2 | 5 | 6 | 6 | 2 | 18 | |
Promyelocytic leukemia acute | D015473 | C92.4 | 2 | 1 | 3 | 2 | — | 8 | |
Philadelphia chromosome | D010677 | — | 1 | — | 1 | — | 2 | ||
Non-hodgkin lymphoma | D008228 | C85.9 | — | — | 1 | 1 | — | 2 | |
Large b-cell lymphoma diffuse | D016403 | C83.3 | — | — | — | 1 | — | 1 | |
Burkitt lymphoma | D002051 | C83.7 | — | — | — | 1 | — | 1 |
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Leukemia | D007938 | C95 | 12 | 30 | 20 | — | — | 54 | |
Monocytic leukemia acute | D007948 | 4 | 6 | 2 | — | 1 | 11 | ||
Myelomonocytic leukemia acute | D015479 | C92.5 | 4 | 5 | 1 | — | 1 | 10 | |
Erythroblastic leukemia acute | D004915 | EFO_1001257 | C94.0 | 4 | 5 | 1 | — | 1 | 10 |
Megakaryoblastic leukemia acute | D007947 | C94.2 | 3 | 5 | 1 | — | 1 | 9 | |
Myeloid leukemia | D007951 | C92 | 2 | 5 | 1 | — | 1 | 7 | |
Liver neoplasms | D008113 | EFO_1001513 | C22.0 | 1 | 4 | 1 | — | 1 | 6 |
Anemia | D000740 | EFO_0004272 | D64.9 | 1 | 3 | 2 | — | 1 | 5 |
Lymphoma | D008223 | C85.9 | — | — | 4 | — | 1 | 5 | |
Myelomonocytic leukemia chronic | D015477 | C93.1 | 2 | 1 | 1 | — | 1 | 4 |
Show 5 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Bcr-abl positive chronic myelogenous leukemia | D015464 | EFO_0000340 | 1 | 4 | — | — | — | 5 | |
Basophilic leukemia acute | D015471 | C94.8 | 1 | 3 | — | — | — | 3 | |
Eosinophilic leukemia acute | D015472 | 1 | 3 | — | — | — | 3 | ||
Biphenotypic leukemia acute | D015456 | C95.0 | 1 | 3 | — | — | — | 3 | |
Graft vs host disease | D006086 | D89.81 | — | 2 | — | — | — | 2 | |
Myeloid sarcoma | D023981 | C92.3 | — | 1 | — | — | — | 1 | |
Multiple myeloma | D009101 | C90.0 | — | 1 | — | — | — | 1 | |
Myeloproliferative disorders | D009196 | D47.1 | — | 1 | — | — | — | 1 | |
B-cell lymphoma | D016393 | — | 1 | — | — | — | 1 |
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Fibrosis | D005355 | 1 | — | — | — | — | 1 |
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name | ILOPERIDONE |
INN | iloperidone |
Description | Iloperidone is a member of the class of piperidines that is the 4-acetyl-2-methoxyphenyl ether of 3-(piperidin-1-yl)propan-1-ol which is substituted at position 4 of the piperidine ring by a 6-fluoro-1,2-benzoxazol-3-yl group. A member of the group of second generation antipsychotics (also known as an atypical antipsychotics), it is used for the treatment of schizophrenia. It has a role as a serotonergic antagonist, a dopaminergic antagonist and a second generation antipsychotic. It is a monoamine, an organofluorine compound, a tertiary amino compound, a methyl ketone, a member of 1,2-benzoxazoles, a member of piperidines, an aromatic ether and an aromatic ketone. |
Classification | Small molecule |
Drug class | antipsychotics (risperidone type) |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | COc1cc(C(C)=O)ccc1OCCCN1CCC(c2noc3cc(F)ccc23)CC1 |
Identifiers
PDB | — |
CAS-ID | 133454-47-4 |
RxCUI | 73178 |
ChEMBL ID | CHEMBL14376 |
ChEBI ID | 65173 |
PubChem CID | 71360 |
DrugBank | DB04946 |
UNII ID | VPO7KJ050N (ChemIDplus, GSRS) |
Target
Agency Approved
No data
Alternate
HTR7
HTR7
HTR1A
HTR1A
HTR6
HTR6
DRD2
DRD2
Variants
Clinical Variant
No data
Financial
Fanapt - Vanda Pharmaceuticals
$
€
£
₣
![](https://www.pharmakb.com/hubfs/raw_assets/public/ccd-theme/images/generated-html-images/sales-plot.png)
Mock data
Subscribe for the real data
Subscribe for the real data
![](https://www.pharmakb.com/hubfs/raw_assets/public/ccd-theme/images/generated-html-images/sales-plot.png)
Mock data
Subscribe for the real data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
![](https://www.pharmakb.com/hubfs/raw_assets/public/ccd-theme/images/generated-html-images/top-terms-plot.png)
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 867 documents
View more details
Safety
Black-box Warning
Black-box warning for: Fanapt, Iloperidone
Adverse Events
Top Adverse Reactions
![](https://www.pharmakb.com/hubfs/raw_assets/public/ccd-theme/images/generated-html-images/top-adverse-reactions-plot.png)
Mock data
Subscribe for the real data
Subscribe for the real data
5,366 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more